Stock listing
Abera Bioscience Ab
Selected listing: ABERA · NGM · SEK · SE
Abera Bioscience Ab (NGM:ABERA), Health Technology. Latest release May 12, 2026: ABERA: 7% organic growth and stable margins in Q1 2026, with strong energy…
- Ticker
- NGM:ABERA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NGM
- Currency
- SEK
About Abera Bioscience Ab
Abera Bioscience AB is a public company based in Sweden, trading under the ticker ABERA. Abera Bioscience focuses on developing innovative solutions in the biotechnology sector.
Latest news from Abera Bioscience Ab
ABERA: 7% organic growth and stable margins in Q1 2026, with strong energy and infrastructure demand
May 12, 2026
ABERA: Transition to clinical-stage vaccines, strong financing, and expanded R&D drive future growth
February 12, 2026
ABERA: Secured funding and positive R&D milestones drive clinical progress despite ongoing losses
November 13, 2025
ABERA: Positive preclinical results and new funding drive clinical trial preparations and liquidity
August 21, 2025
ABERA: Positive Q1 2025 result and strong vaccine pipeline progress, supported by grants
May 13, 2025